Hydroxamate complexes, model

Model Hydroxamate Complexes. Attempts to prepare tris( hydroxamate) complexes of Co (III) with benzohydroxamic acid or its... 

Chromic Ferrichrome Complexes. The spectra for the model chromic hydroxamate complexes are reproduced in Figure 6. Since the visible and CD spectra of the isomers are wholly dominated by the metal complex chromophore, these data can be used to characterize and to identify coordination isomers of complexes formed by the siderophores. The preparation and characterization of the chromic complexes of des-ferriferrichrome and desferriferrichrysin have been reported (3). Although an examination of molecular models for both complexes shows two coordination isomers are possible (A-cis and A-cis), both chromic complexes consist exclusively of the A-cis isomer. These results agree with x-ray crystallographic investigations which have shown that both ferri-chrysin and ferrichrome A crystallize as only the A-cis isomer (14, 15). Both chromic complexes have identical CD spectra which are the same as the A-cis Cr(men)3 spectrum (Figure 6). 

Fe(III) displacement of Al(III), Ga(III), or In(III) from their respective complexes with these tripodal ligands, have been determined. The M(III)-by-Fe(III) displacement processes are controlled by the ease of dissociation of Al(III), Ga(III), or In(III) Fe(III) may in turn be displaced from these complexes by edta (removal from the two non-equivalent sites gives rise to an appropriate kinetic pattern) (343). Kinetics and mechanism of a catalytic chloride ion effect on the dissociation of model siderophore-hydroxamate iron(III) complexes chloride and, to lesser extents, bromide and nitrate, catalyze ligand dissociation through transient coordination of the added anion to the iron (344). A catechol derivative of desferrioxamine has been found to remove iron from transferrin about 100 times faster than desferrioxamine itself it forms a significantly more stable product with Fe3+ (345). 

Trispyrazolylborates are models for tris-histidine active sites in zinc enzymes, e.g., the matrix metalloproteinases involved in breakdown of extracellular matrices. Inhibition of these metalloproteinases may prove valuable in the treatment of, inter alios, cancer and arthritis, so efforts are being made to find appropriate ligands to block the zinc active site. The search has recently moved on from hydroxamates to hydroxypyridinones - l-hydroxy-2-pyridinone is a cyclic analogue of hydroxamic acid. As reported in Section II.B.2 earlier, hydroxypyridinones form stable five-coordinate complexes on reaction with hydrotris(3,5-phenylmethylpyrazolyl)borate zinc hydroxide. Modeling studies suggest that hydroxypyridinonate ligands should be able to access the active site in the enzyme with ease (110). 

A multiple-path mechanism has been elaborated for dissociation of the mono- and binuclear tris(hydroxamato)-iron(III) complexes with dihydroxamate ligands in aqueous solution. " Iron removal by edta from mono-, bi-, and trinuclear complexes with model desferrioxamine-related siderophores containing one, two, or three tris-hydroxamate units generally follows first-order kinetics though biphasic kinetics were reported for iron removal from one of the binuclear complexes. The kinetic results were interpreted in terms of discrete intrastrand ferrioxamine-type structures for the di-iron and tri-iron complexes of (288). " Reactivities for dissociation, by dissociative activation mechanisms, of a selection of bidentate and hexadentate hydroxamates have been compared with those of oxinates and salicylates. ... 

In the recent literature, many examples of A/BPs containing benzophenones can be found. A first example concerns the study of HDACs. These enzymes catalyze the hydrolysis of acetylated lysine amine side chains in histones and are thus involved in the regulation of gene expression. There are approximately 20 human HDACs, which are divided into three classes (I, II, and III). Class I and II HDACs are zinc-dependent metallohydrolases that do not form a covalent bond with their substrates during their catalytic process, which is similar to MMPs. It has been found that hydroxamate 65 (SAHA, see Fig. 5) is a potent reversible inhibitor of class I and II HDACs. In 2007, Cravatt and coworkers reported the transformation of SAHA into an A/BP by installment of a benzophenone and an alkyne moiety, which resulted in SAHA-BPyne (66) [73]. They showed that the probe can be used for the covalent modification and enrichment of several class I and class II HDACs from complex proteomes in an activity-dependent manner. In addition, they identified several HDAC-associated proteins, possibly arising from the tight interaction with HDACs. Also, the probe was used to measure differences in HDAC content in human disease models. Later they reported the construction of a library of related probes and studied the differences in HDAC labeling [74], Their most... 

N-methyl derivative resulted in oxidation of the ligand with concomitant reduction of Co (III) to Co (II). The preparation of tris (benzohydroxa-mato) chromium (III), Cr(benz)3, was successful and resulted in the separation and characterization of its two geometric isomers (2). The half-lives for isomerization of these complexes near physiological conditions is on the order of hours. To facilitate the separation of all four optical isomers of a simple model tris (hydroxamate) chromium (III) complex, we prepared (using Z-menthol as a substituent) the optically active hydroxamic acid, N-methyl-Z-menthoxyacethydroxamic acid (men). This resulted in the separation of the two cis diastereoisomers of tris(N-methyl-Z-menthoxyacethydroxamato) chromium (III) from the trans diastereoisomers and their characterization by electronic absorption and circular dichroism spectra. 

The visible and circular dichroism spectra of the chromic siderophore complexes are closely related to the corresponding spectra of simple model complexes of hydroxamate or catecholate ligands. This provides a spectroscopic probe for structure in assigning the geometries of the siderophore complexes. 

Hydroxamic acids and their amino acid derivatives formed a series of dioxomolybdenum(VI) complexes of the type cis-[Mo02(hdx)2] and [Mo02(hdxamc)2] (hdxH, (10) hdxamcH, (11)), which are attractive as models for siderophores and for the development of metal-chelating drugs. 

Wasserman and Hodge (290) used molecular dynamics to dock thermolysin inhibitors to an approximate model of the enzyme, with flexibility in the active site (3 8 of 314 residues) and ligand and with the rest of the enzyme represented by a grid approximation. A solvation model was used to compensate for desolvation in complex formation. To get 22 of 25 runs to orient the hydroxamate function correctly, the hydroxamate oxygens of the starting conformation were initialized within 4 A of the zinc. If they were allowed to vary to 8 A, then only 3 of 24 runs placed the ligand correctly. Obviously, there is a serious sampling problem. 

Other solvent degradation products derived from the diluent as well as from TBP may arise. Butyl lauryl phosphoric acid (HELP) has been used as a model for diluent derived diesters of phosphoric acid and at concentrations above 2xlO M enhances Zr extraction by TBP. HELP is not removed by alkali washing of the solvent but BLP is transferred into water at low ionic strength. Dialkylphosphorane complexes of Zr may also arise from irradiation and can stabilize emulsions. Diluent derived hydroxamic acids are present at too low a concentration (10 -10 M) to completely account for the extent of zirconium retention which occurs in... 

One subset of Schiff base complexes are the hydrazone complexes which have a R—C=N—N functional group instead of the R C=N—C functionality. These compounds have been prepared as models for bromoperoxidase389 and other biological systems.390 In the solid state, the hydrazones have coordination patterns similar to those of the Schiff bases and the majority of the complexes are oxovanadium(V) hexadentate or pentacoordinate complexes with tridentate 02N donor sets (see Table 5). While most structures contain alkoxide donors,390-403 complexes have been reported with diols and catechols,129,404,405 hydroxamic acids,288,391 hydroxy quinolinate,406, 7 and benzoylhydrazine.408 In addition, dioxo,375,409-412 oxo-bridged... 

---